Understand the source comparison
Epithalon Sermorelin for Longevity + GH: Peptide Stack Comparison
Epithalon Telomerase activation (hTERT upregulation) 5–10mg/day for 10–20 days, cycled every 4–6 months 30–45 minutes Telomere length increase (8–12% mean elongation in clinical studies) Best for cellular-level replicative preservation. Addresses genomic insta
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Epithalon
- Telomerase activation (hTERT upregulation)
- 5–10mg/day for 10–20 days, cycled every 4–6 months
- 30–45 minutes
- Telomere length increase (8–12% mean elongation in clinical studies)
- Best for cellular-level replicative preservation. Addresses genomic instability directly
- Sermorelin
- GHRH receptor agonism (pituitary GH pulse stimulation)
- 0.2–0.3mg nightly before sleep
- 8–12 minutes
- IGF-1 elevation (50–70% increase in 24-hour GH secretion)
- Best for systemic anabolic support. Restores age-related GH decline without receptor desensitisation
- Combined Stack
- Dual-pathway intervention (telomere + GH axis)
- Epithalon cycled + sermorelin continuous
- Variable (independent clearance)
- Synergistic coverage of genomic stability + proteostasis
- Addresses two independent ageing hallmarks without pathway interference. Complementary, not redundant
- This comparison underscores why epithalon sermorelin for longevity + gh protocols outperform single-peptide approaches: you're intervening at the chromosomal level and the systemic hormonal level simultaneously, covering more biological ageing terrain with mechanistically distinct tools.